Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/096760 stock hub

KRX/096760 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/096760is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

285.4B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/096760

In the news

Latest news · KRX/096760

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E4.9

P25 12P50 23.1P75 39.5

ROE20.7

P25 -17.1P50 0.7P75 8.5

ROIC15.2

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/096760 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

KRW

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	127
Enterprise value	KRW 883.2B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7096760004
Last refreshed	2026-05-10
Market cap	KRW 285.4B
Price	KRW 4,125
Price currency	KRW
Rev Per Employee	7,634,372,327.48x
Sector	Healthcare
Sic	2834
Symbol	krx/096760
Website	https://www.jw-holdings.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	20.5%
EV Earnings	15.1x
EV/EBIT	5.4x
EV/EBITDA	4.26x
EV/FCF	6.58x
EV/Sales	0.91x
FCF yield	47.05%
P/B ratio	0.48x
P/E ratio	4.9x
P/S ratio	0.29x
PE Ratio10 Y	45.45x
PE Ratio3 Y	8.18x
PE Ratio5 Y	12.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.88%
EBITDA Margin	21.38%
FCF margin	13.85%
Gross margin	50.69%
Gross Profit	KRW 491.5B
Gross Profit Growth	12.92%
Gross Profit Growth Q	22.38%
Gross Profit Growth3 Y	7.11%
Gross Profit Growth5 Y	9.85%
Net Income	KRW 58.5B
Net Income Growth	-6.57%
Net Income Growth Q	206.12%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	38.23%
Net Income Growth5 Y	45.2%
Pretax Margin	14.88%
Profit Margin	6.03%
Profit Per Employee	KRW 460.7M
Profitable Years	4
ROA	8.24
Roa5y	6.66
ROCE	21.14
ROE	20.7
Roe5y	14.8
ROIC	15.19
Roic5y	10.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.73%
Cagr15y	9.34%
Cagr1y	43.03%
Cagr3y	12.28%
Cagr5y	1.89%
Div CAGR10	13.1%
Div CAGR3	26.98%
Div CAGR5	20.21%
EPS Growth	-3.78
EPS Growth Q	213
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	39.99
EPS Growth5 Y	46.97
FCF Growth	63.47%
FCF Growth3 Y	53.96%
FCF Growth5 Y	18.8%
OCF Growth	67.19%
OCF Growth3 Y	16.16%
OCF Growth5 Y	8.54%
Revenue Growth	9.22x
Revenue Growth Q	15.24x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	3.9x
Revenue Growth5 Y	4.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.78
Assets	KRW 1.2T
Cash	KRW 89.5B
Current Assets	KRW 400.9B
Current Liabilities	KRW 456.7B
Debt	KRW 359.6B
Debt EBITDA	KRW 1.73
Debt Equity	KRW 0.6
Debt FCF	KRW 2.68
Equity	KRW 594.6B
Interest Coverage	8.24
Liabilities	KRW 636.6B
Long Term Assets	KRW 830.3B
Long Term Liabilities	KRW 179.8B
Net Cash	KRW -270.1B
Net Cash By Market Cap	KRW -94.63
Net Debt EBITDA	KRW 1.3
Net Debt Equity	KRW 0.45
Net Debt FCF	KRW 2.01
Tangible Book Value	KRW 72B
Tangible Book Value Per Share	KRW 1,041
WACC	5.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.88
Inventory Turnover	3.01
Net Working Capital	KRW 113B
Quick ratio	0.51
Working Capital	KRW -55.8B
Working Capital Turnover	KRW -19.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.9%
Dividend Growth	0%
Dividend Growth Years	6%
Dividend per share	KRW 155
Dividend Years	1
Dividend Yield	3.76%
Ex Div Date	2026-03-31
Last Dividend	KRW 215
Payout Frequency	Annual
Payout Ratio	31.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-31.64%
1Y total return	43%
200-day SMA	3,707
3Y total return	41.56%
50-day SMA	4,160.8
50-day SMA vs 200-day SMA	50over200
5Y total return	9.81%
All Time High	16,326.2
All Time High Change	-74.73%
All Time High Date	2016-09-27
All Time Low	539.9
All Time Low Change	664.06%
All Time Low Date	2008-10-27
ATR	138.4
Beta	0.66
Beta1y	0.09
Beta2y	0.17
Ch YTD	14.9
High	4,160
High52	4,495
High52 Date	2026-02-23
High52ch	-8.23%
Low	4,080
Low52	3,020
Low52 Date	2025-05-08
Low52ch	37.04%
Ma50ch	-0.86%
Price vs 200-day SMA	11.28%
RSI	46.27
RSI Monthly	61.07
RSI Weekly	54.86
Sharpe ratio	1.14x
Sortino ratio	1.91
Total Return	6.66%
Tr YTD	20.89
Tr15y	281.73%
Tr1m	7.28%
Tr1w	-2.71%
Tr3m	6.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 163.7B
Operating Income Growth	11.54
Operating Income Growth Q	9.9
Operating Income Growth3 Y	13.93
Operating Income Growth5 Y	34.4
Operating margin	16.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36,028,961%
Net Borrowing	-78,623,321,410
Shares Insiders	47.93%
Shares Institutions	8.91%
Shares Out	69,190,827
Shares Qo Q	-0.77%
Shares Yo Y	-2.9%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 134.3B
Average Volume	120,624.15x
Bv Per Share	3,859.8
CAPEX	KRW -29.4B
Ch10y	-46.04
Ch15y	186.7
Ch1m	7.28
Ch1w	-2.71
Ch1y	35.91
Ch3m	1.1
Ch3y	25.79
Ch5y	-8.06
Ch6m	21.15
Change	0.12%
Change From Open	0
Close	4,120
Days Gap	0.12
Depreciation Amortization	43,643,361,000
Dollar Volume	417,441,750
Earnings Date	2026-05-15
EBIT	KRW 163.7B
EBITDA	KRW 207.3B
EPS	KRW 841
F Score	7
FCF	KRW 134.3B
FCF EV Yield	15.2x
FCF Per Share	KRW 1,941
Financing CF	-111,527,668,860
Fiscal Year End	December
Founded	1,945
Goodwill	111,289,160,000
Graham Number	8546.17365
Graham Upside	107.2
Income Tax	KRW 28.8B
Investing CF	-24,654,256,240
Is Primary Listing	1
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Last Split Date	2023-12-27
Last Split Type	Forward
Lynch Fair Value	KRW 21,025
Lynch Upside	409.7
Ma150	3,790.5
Ma150ch	8.82%
Ma20	4,226
Ma20ch	-2.39%
Net CF	27,792,129,640
Next Earnings Date	2026-05-15
Open	4,125
P FCF Ratio	2.13
P OCF Ratio	1.74
Payment Date	2026-04-24
Position In Range	56.25
Ppne	489,058,463,330
Price Date	2026-05-08
Price EBITDA	KRW 1.38
Ptbv Ratio	3.96
Relative Volume	0.85x
Revenue	969,565,285,590x
Tax By Revenue	2.97x
Tax Rate	19.94%
Tr6m	27.46%
Volume	101,198
Z Score	1.54

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/096760 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.8%

$155 annual per share

Payout ratio

+31.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.2%

6 consecutive years of growth

Total shareholder yield

+6.7%

Next ex-dividend date: 2026-03-31

Performance

KRX/096760 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/096760?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.9%

Share of float held by funds and institutions

Insider ownership

+47.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.9%

Negative means the company is buying back shares.

Technical

KRX/096760 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.3

Neutral momentum band

Price vs 200-day MA

+11.3%

50/200-day relationship not available

Beta (5Y)

0.66

Less volatile than the market

Sharpe ratio

1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/096760

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/096760 stock rating?

krx/096760 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/096760 analysis?

The full report lives at /stocks/krx/096760/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/096760?

The latest report frames krx/096760 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/096760 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.